MYELODYSPLASTIC SYNDROME

Refine Results:
All Categories Epidemiology and Etiology (85) Prevention and Screening (27) Diagnosis and Staging (136) Treatment (176) Supportive Oncology (31)

CME

Performance Improvement Strategies in Myelodysplastic Syndromes (MDS)
An interactive CME program provided by Med-IQ
OncologySTAT CME
Addressing the Risk of TLS in Adult Patients: Case Studies for the Practicing Physician
An interactive CME program provided by Med-IQ
OncologySTAT CME
William Bensinger, MD (Consultservice 1): Practical Aspects of HSCT for Hematologic Malignancies
An interactive CME program powered by Real CME
OncologySTAT CME

News

Transplant Protocol Benefits Elderly With Hematologic Cancers
Elsevier Global Medical News, 2011 Nov 1, MA Moon
New Diarrheal Syndrome Tied to Cord-Blood Transplants
Elsevier Global Medical News, 2011 Aug 31, MA Moon
No Increased AML Risk in First-Degree Relatives
Elsevier Global Medical News, 2011 Jul 11, S Freeman
FDA Keeping an Eye on New Malignancy Concerns With Lenalidomide
Elsevier Global Medical News, 2011 Apr 11, K Wachter
NICE Finally Recommends Azacitidine
Elsevier Global Medical News, 2011 Mar 23, J Smith
More News ›

Journal Scans: Research

The Degree of Neutropenia Has a Prognostic Impact in Low Risk Myelodysplastic Syndrome
Leuk Res, 2012 Mar 1, I Cordoba, et al
Free Journal Content
Clinical Significance of SF3B1 Mutations in Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
Blood, 2011 Dec 8, L Malcovati, et al
Transient/Reversible Ring Sideroblasts in Bone Marrow of Patients Post Cytotoxic Therapies for Primary Malignancies
Leuk Res, 2011 Dec 1, CY Ok, et al
Treatment by Lenalidomide in Lower Risk Myelodysplastic Syndrome With 5q Deletion—The GFM Experience
Leuk Res, 2011 Nov 1, F Le Bras, et al
Weekly Standard Doses of rh-EPO Are Highly Effective for the Treatment of Anemic Patients With Low-Intermediate 1 Risk Myelodysplastic Syndromes
Leuk Res, 2011 Nov 1, E Balleari, et al
More Journal Scans: Research ›

Journal Scans: Review

Risk Factors for Acute GVHD and Survival After Hematopoietic Cell Transplantation
Blood, 2012 Jan 5, M Jagasia, et al
Lenalidomide in del 5q MDS: Responses and Side Effects Revisited
Leuk Res, 2011 Nov 1, RV Tiu, et al
Treatment of Higher-Risk Myelodysplastic Syndrome
Semin Oncol, 2011 Oct 1, G Garcia-Manero
Classification and Prognostic Evaluation of Myelodysplastic Syndromes
Semin Oncol, 2011 Oct 1, M Cazzola, et al
Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes
Semin Oncol, 2011 Oct 1, TM Kadia, et al
More Journal Scans: Review ›

Chemotherapy Regimens

Lenalidomide (Myelodysplastic syndrome)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Decitabine (Myelodysplastic syndrome)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Azacitidine (Myelodysplastic syndrome)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)

Conference Coverage

16th Congress of EHA
June 9-12 2011 London

Updated Key Points: Myelodysplastic Syndrome

Summary information about myelodysplastic syndrome has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

CME

Stay current and earn valuable credits by participating in customized online programs.
Read more ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration